- Chih-Lin Lin, Jia-Horng Kao. Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection. Clin Mol Hepatol 2023;29:605

- Young Mi Hong, Ki Tae Yoon. Definition and Management of the Immune Tolerance Phase in Chronic Hepatitis B. Korean J Gastroenterol 2022;79:156

- Xue Cong, Shuyao Song, Yingtao Li, Kaiyang Song, Cameron MacLeod, Yujie Cheng, Jun Lv, Canqing Yu, Dianjianyi Sun, Pei Pei, Ling Yang, Yiping Chen, Iona Millwood, Shukuan Wu, Xiaoming Yang, Rebecca Stevens, Junshi Chen, Zhengming Chen, Liming Li, Christiana Kartsonaki, Yuanjie Pang. Comparison of models to predict incident chronic liver disease: a systematic review and external validation in Chinese adults. BMC Med 2024;22

- Yi‐Te Lee, Naoto Fujiwara, Ju Dong Yang, Yujin Hoshida. Risk stratification and early detection biomarkers for precision HCC screening. 2023;78:319

- Giacomo Emanuele Maria Rizzo, Giuseppe Cabibbo, Antonio Craxì. Hepatitis B Virus-Associated Hepatocellular Carcinoma. Viruses 2022;14:986

- Gi-Ae Kim, Young-Suk Lim, Seungbong Han, Gwang Hyeon Choi, Won-Mook Choi, Jonggi Choi, Dong Hyun Sinn, Yong-Han Paik, Jeong-Hoon Lee, Yun Bin Lee, Ju-Yeon Cho, Nae-Yun Heo, Man-Fung Yuen, Vincent Wai-Sun Wong, Stephen L. Chan, Hwai-I Yang, Chien-Jen Chen. Viral Load–Based Prediction of Hepatocellular Carcinoma Risk in Noncirrhotic Patients With Chronic Hepatitis B. Ann Intern Med 2024;177:1308

- Naoto Kubota, Naoto Fujiwara, Yujin Hoshida. Hepatobiliary Cancers: Translational Advances and Molecular Medicine. 2024.

- Yashasavi Sachar, Mayur Brahmania, Renumathy Dhanasekaran, Stephen E. Congly. Screening for Hepatocellular Carcinoma in Patients with Hepatitis B. Viruses 2021;13:1318

- Jung Hwan Yu, Soon Gu Cho, Young-Joo Jin, Jin-Woo Lee. The best predictive model for hepatocellular carcinoma in patients with chronic hepatitis B infection. Clin Mol Hepatol 2022;28:351

- Helen Weidemann, Kristen Yeh, Krystal Hunter, Satyajeet Roy. Risk Factors and Comorbidities Associated With Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection. J Prim Care Community Health 2024;15

- Ji Hoon Kim. 2018 Korean Association for the Study of the Liver (KASL) Clinical Practice Guidelines of Chronic Hepatitis B: What's Different?. Korean J Gastroenterol 2019;73:132

- Tsai-Chung Li, Chia-Ing Li, Chiu-Shong Liu, Wen-Yuan Lin, Chih-Hsueh Lin, Sing-Yu Yang, Cheng-Chieh Lin. Risk score system for the prediction of hepatocellular carcinoma in patients with type 2 diabetes: Taiwan Diabetes Study. Seminars in Oncology 2018;45:264

- Thodoris Voulgaris, Margarita Papatheodoridi, Pietro Lampertico, George V. Papatheodoridis. Clinical utility of hepatocellular carcinoma risk scores in chronic hepatitis B. Liver International 2020;40:484

- Ae Jeong Jo, Won‐Mook Choi, Hyo Jeong Kim, So Hyun Choi, Seungbong Han, Min Jung Ko, Young‐Suk Lim. A risk scoring system to predict clinical events in chronic hepatitis B virus infection: A nationwide cohort study. Journal of Viral Hepatitis 2022;29:115

- Jia‐Horng Kao, Tsung‐Hui Hu, Jidong Jia, Masayuki Kurosaki, Young‐Suk Lim, Han‐Chieh Lin, Dong Hyun Sinn, Yasuhito Tanaka, Vincent Wai‐Sun Wong, Man‐Fung Yuen. East Asia expert opinion on treatment initiation for chronic hepatitis B. Aliment Pharmacol Ther 2020;52:1540

- Lung-Yi Mak. Disease modifiers and novel markers in hepatitis B virus-related hepatocellular carcinoma. JLC 2024;24:145

- Yao-Chun Hsu, Cheng-Hao Tseng, Yen-Tsung Huang, Hwai-I Yang. Application of Risk Scores for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: Current Status and Future Perspective. Semin Liver Dis 2021;41:285

- Nae-Yun Heo. Are the Patients in the Immune Tolerant Phase of Chronic Hepatitis B far from Hepatocellular Carcinoma or Death?. Korean J Gastroenterol 2019;74:66

- Jiang Guo, Xue-Song Gao. Prediction models for development of hepatocellular carcinoma in chronic hepatitis B patients. WJCC 2021;9:3238

- Won-Mook Choi, Gi-Ae Kim, Jonggi Choi, Seungbong Han, Young-Suk Lim. Increasing on-treatment hepatocellular carcinoma risk with decreasing baseline viral load in HBeAg-positive chronic hepatitis B. 2022;132

- . KASL clinical practice guidelines for management of chronic hepatitis B. Clin Mol Hepatol 2019;25:93

- George V. Papatheodoridis, Thodoris Voulgaris, Margarita Papatheodoridi, W. Ray Kim. Risk Scores for Hepatocellular Carcinoma in Chronic Hepatitis B: A Promise for Precision Medicine. Hepatology 2020;72:2197

- Naoto Kubota, Naoto Fujiwara, Yujin Hoshida. Clinical and Molecular Prediction of Hepatocellular Carcinoma Risk. JCM 2020;9:3843

- Soo Ryang Kim, Soo Ki Kim. Hepatocellular Carcinoma and Hepatitis: Advanced Diagnosis and Management with a Focus on the Prevention of Hepatitis B-Related Hepatocellular Carcinoma. Diagnostics 2023;13:3212

- Dong Hyun Sinn. Natural History and Treatment Indications of Chronic Hepatitis B. Korean J Gastroenterol 2019;74:245

- . KASL clinical practice guidelines for management of chronic hepatitis B. Clin Mol Hepatol 2022;28:276
